$15.05
-0.28-1.83%
Pre-Market: 7:59 PM EDT
Comments
Loading...
Neurogene (NGNE) Forecast
NewsEarningsNeurogene (NGNE) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestNeurogene (NASDAQ:NGNE) Stock Quotes, Forecast and News Summary
Neurogene Stock (NASDAQ: NGNE) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Neurogene (NGNE) stock?
You can purchase shares of Neurogene (NASDAQ:NGNE) through any online brokerage.
Who are Neurogene (NGNE) competitors?
Other companies in Neurogene’s space includes: Macrogenics (NASDAQ:MGNX), Precigen (NASDAQ:PGEN), Zentalis Pharma (NASDAQ:ZNTL), Fate Therapeutics (NASDAQ:FATE) and Tevogen Bio Holdings (NASDAQ:TVGN).
What is the forecast, or price target, for Neurogene (NGNE) stock?
Neurogene has a consensus price target of $60.80.
What is the current price for Neurogene (NGNE)?
The stock price for Neurogene (NASDAQ: NGNE) is $15.05 last updated November 20, 2024 at 7:59 PM EST.
Does Neurogene (NGNE) pay a dividend?
There are no upcoming dividends for Neurogene.
When is Neurogene (NASDAQ:NGNE) reporting earnings?
Neurogene’s Q3 earnings are confirmed for Monday, November 18, 2024.
Is Neurogene (NGNE) going to split?
There is no upcoming split for Neurogene.
What sector and industry does Neurogene (NGNE) operate in?
Neurogene is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.